相关实验视频

Updated: May 2, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

代理MD:授权语言代理人进行风险预测,使用大规模的临床工具学习

Qiao Jin, Zhizheng Wang, Yifan Yang

    ArXiv
    |October 1, 2025
    PubMed
    概括

    AgentMD是一种新型语言代理,自动策划和应用临床计算器 (RiskCalcs),改善医疗分析和患者护理效率. 这种人工智能工具克服了可用性挑战,通过准确的,基于证据的预测增强了临床决策.

    更多相关视频

    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness03:14

    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

    Published on: December 6, 2024

    1.0K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.3K

    相关概念视频

    Analysis of Population Pharmacokinetic Data01:12

    Analysis of Population Pharmacokinetic Data

    Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
    996
    Statistical Methods for Analyzing Epidemiological Data01:25

    Statistical Methods for Analyzing Epidemiological Data

    Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
    1.3K
    Steps in Outbreak Investigation01:18

    Steps in Outbreak Investigation

    In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
    779
    Statistical Software for Data Analysis and Clinical Trials01:12

    Statistical Software for Data Analysis and Clinical Trials

    Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
    1.7K
    Hazard Rate01:11

    Hazard Rate

    The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
    525
    Hazard Ratio01:12

    Hazard Ratio

    The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
    For example, in a clinical trial...
    756